knight therapeutics reports second quarter 2020 results

Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross

Aug 13, 2020 · Welcome to the Knight Therapeutics Inc. 2020 Second Quarter Final Results Conference Call. Before turning the call over to Jonathan Ross Goodman, CEO of Knight Knight Therapeutics Reports First Quarter 2020 ResultsJun 26, 2020 · Knight Therapeutics Reports First Quarter 2020 Results Investing News Network - June 26th, 2020 Knight Therapeutics reported financial results for its first quarter ended March 31, 2020.

Knight Therapeutics Reports First Quarter 2020 Results

Jun 26, 2020 · MONTREAL, June 26, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight" or the Company), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2020.All currency amounts are in thousands except for share and per share amounts. Knight Therapeutics Reports First Quarter 2021 ResultsMay 14, 2021 · MONTREAL, May 14, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the Company), a leading pan-American (ex Knight Therapeutics Reports Fourth Quarter and Year End Knight Therapeutics Inc. (TSX:GUD) ("Knight" or "the Company"), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2020. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.

Knight Therapeutics Reports Fourth Quarter and Year End

Mar 25, 2021 · Knight Therapeutics Reports Fourth Quarter and Year End 2020 Results MONTREAL, March 25, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the Company), a leading pan Knight Therapeutics Reports Fourth Quarter and Year End Mar 25, 2021 · MONTREAL, March 25, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the Company), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2020. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian Knight Therapeutics Reports Third Quarter 2020 Results Nov 13, 2020 · MONTREAL, Nov. 13, 2020 (GLOBE NEWSWIRE) Knight Therapeutics Inc. (TSX:GUD) (Knight or the Company), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2020.

Knight Therapeutics Reports Fourth Quarter and Year End

Mar 25, 2021 · Gross margin:For the quarter ended December 31 , 2020, the gross margin decreased from 49% to 36% compared to the same period in the prior year due to the consolidation of GBT's results, change in product mix and an inventory write-off of $3,249 as a result of the impact of COVID-19 on certain new product launches. The gross margin would have been 40%, an increase of 4%, from